The story begins with the launch of Saccharomyces Boulardii CNCM I 745® on the Belgian and Luxembourg market under the name Enterol®.
Biocodex quickly became the leader in probiotic yeasts in Belgium and worldwide.
Building on this success, Biocodex has continued its development by becoming a recognized expert in microbiota.
In order to consolidate and share its expertise, Biocodex has created two entities with the objective of promoting and disseminating its research in this field.
Respectively - The Biocodex Microbiota Institute and the Biocodex Microbiota Foundation.
Biocodex Benelux has also developed over the years its presence in other therapeutic areas such as dermatology.
Its flagship products are known as Flammazine and Kelo Cote.
Very recently Biocodex acquired the pharmaceutical laboratory Iprad.
Iprad with the brands Saforelle, Mucogyne is the leader in the feminine hygiene category in France, Belgium and Luxembourg.
With this acquisition, Biocodex Benelux now has three pillars of growth.
Our 3 pillars of growth :
(burns and skin renewal)
Today, 52 dedicated employees are working to further develop our expertise in these three therapeutic areas.
Biocodex Benelux ranks among the top 20 pharmaceutical companies in Belgium and Luxembourg.
Our development and success are also the result of the values we stand for and the talent of our employees.
The Biocodex teams are bound by common values, which play a driving role in our business. They belong to all our teams, because they are the ones who defend them. Our values are part of Biocodex's DNA and are fourfold: we dare to innovate, we act collectively, we build relationships based on fairness and we care for our ecosystem.